Linguistic Validation
Linguistic Validation for Clinical Outcome Assessments
Spanish–English COA translation and cognitive debriefing by a physician with clinical experience in psychiatry, neurology, and internal medicine.
What Linguistic Validation Requires
Linguistic validation is not standard translation. When a clinical outcome assessment (a patient-reported outcome, a clinician-rated scale, or an observer-reported instrument) is adapted into a new language, the goal is conceptual equivalence, not literal accuracy. A word-for-word translation of the PHQ-9 into Spanish is not a validated Spanish PHQ-9.
That distinction is what makes physician involvement in LV projects useful. I understand what each item on a psychiatric or neurological scale is measuring. I know how patients with depression, anxiety, schizophrenia, or autism describe their experiences in clinical settings, and I know when a translated item would elicit a different construct from a Spanish-speaking respondent than the original elicits from an English-speaking one.
I follow the methodological standards established by ISPOR and the FDA PRO Guidance, and I work within the workflows of LV firms and eCOA providers as a qualified translator and clinician reviewer.
Services
Forward Translation
I produce forward translations of COAs from English into Spanish, with documentation of translation decisions and rationale for terminology choices. I flag items with conceptual translation challenges and propose alternatives with clinical justification.
Clinician Review
As a physician, I can serve as the clinician reviewer in the LV process: the step that evaluates whether translated items are clinically appropriate, grammatically natural for a clinical context, and likely to be interpreted as intended by both patients and clinical raters. This is a role that requires medical training and familiarity with the therapeutic area, not just language proficiency.
Cognitive Debriefing Support
I participate in the cognitive debriefing phase by recruiting patients and reviewing transcripts and interview data from patient focus groups, identifying conceptual discrepancies between the translated item and the respondent's interpretation, and recommending item revisions with clinical rationale.
Back Translation Review
I review back translations for semantic fidelity and flag discrepancies that indicate a conceptual problem in the forward translation, distinguishing between back translation artifacts and genuine translation errors.
Reconciliation and Harmonization
For projects requiring reconciliation across multiple forward translations or harmonization across Spanish variants (Mexico and US Spanish), I provide clinical and linguistic rationale for final wording decisions.
Instruments and Therapeutic Areas
My clinical background and translation experience are deepest in the following areas:
Psychiatry and Mental Health
PHQ-9 (Patient Health Questionnaire)
GAD-7 (Generalized Anxiety Disorder scale)
MADRS (Montgomery–Åsberg Depression Rating Scale)
PANSS (Positive and Negative Syndrome Scale)
C-SSRS (Columbia Suicide Severity Rating Scale)
CDSS (Calgary Depression Scale for Schizophrenia)
PCL-5 (PTSD Checklist for DSM-5)
Neurodevelopmental Disorders
Adult autism spectrum disorder instruments
ADOS-2 (Autism Diagnostic Observation Schedule)
SRS-2 (Social Responsiveness Scale)
Neurology
Quality of life and functional status instruments for Parkinson's disease, multiple sclerosis, and epilepsy
Cardiovascular and Internal Medicine
Health-related quality of life (HRQoL) instruments
Symptom burden and treatment satisfaction scales
If your instrument is not on this list, contact me. I work in adjacent therapeutic areas and can assess suitability for a specific project.
How I Work with LV Firms and eCOA Providers
Most of my LV work is as a qualified translator or clinician reviewer embedded in a firm's established methodology. I am familiar with the documentation standards required by regulatory agencies, including FDA, EMA, and ICH, and with the workflows used by major LV firms and eCOA providers.
I work within your existing process. I do not require clients to adopt a different methodology. What I bring is a translator who holds an MD and has clinical experience in the therapeutic areas where most COA validation work is concentrated: psychiatry, neurology, and chronic disease.
I am based in Chicago, with a planned move to Amsterdam in May 2026. The EU time zone will make coordination with European LV firms and sponsors more practical.
Qualifications
MD — real life training in three different countries
MSc, Global Mental Health — University of Glasgow
ATA-certified translator, English into Spanish
Familiarity with ISPOR LV guidelines and FDA PRO Guidance
Experience with cognitive debriefing, clinician review, and reconciliation phases of LV projects
Member: American Medical Writers Association (AMWA), American Translators Association (ATA)
Frequently Asked Questions
What is linguistic validation?
Linguistic validation is the process of adapting a clinical outcome assessment — such as a patient-reported outcome (PRO), clinician-rated scale, or observer-reported instrument — into a new language while preserving the conceptual meaning of each item. It follows a defined methodology that includes forward translation, clinician review, cognitive debriefing with patients, back translation, and reconciliation. The goal is to produce an instrument that measures the same construct in the target language as the original measures in the source language.
Why does a COA translator need a medical background?
COA instruments are designed to capture specific clinical constructs — severity of depression, frequency of psychotic symptoms, degree of functional impairment. Translating those items accurately requires understanding what the item is measuring clinically, not just what the words mean linguistically. A translator without clinical training can produce a grammatically correct translation that elicits a different construct from respondents. Physician involvement in the translation and review phases reduces that risk.
What is the difference between a PRO, a ClinRO, and an ObsRO?
A patient-reported outcome (PRO) is completed by the patient without clinician interpretation. A clinician-reported outcome (ClinRO) is completed by a trained clinician based on observation or interview — the MADRS and PANSS are examples. An observer-reported outcome (ObsRO) is completed by a caregiver or observer rather than the patient. Each type has distinct translation and validation considerations, particularly in how items should be worded for the intended respondent.
Do you work directly with pharma sponsors or only through LV firms?
Both. I work as a qualified translator and clinician reviewer through LV firms and eCOA providers, and I also work directly with pharmaceutical sponsors and CROs on projects where an internal LV methodology is already in place. Contact me to discuss the structure that works for your project.
Can you validate instruments for US Spanish-speaking populations specifically?
Yes. US Spanish is a valid target variant for studies conducted in the United States, and it differs meaningfully from Latin American or Castilian Spanish in vocabulary, syntax, and cultural framing. I have experience translating and reviewing instruments for US Spanish-speaking populations across multiple therapeutic areas, with particular depth in mental health and chronic disease.
Are you available for expert witness or consulting work related to COA translation?
On a case-by-case basis, yes. If you are involved in a regulatory submission, a clinical trial dispute, or a validation challenge that requires an opinion from a qualified bilingual physician with COA expertise, contact me to discuss the scope.
Work With Me
If you are working on a COA translation project and need a physician translator with depth in psychiatry, neurology, or chronic disease (or if you need a clinician reviewer for an ongoing LV project) I would be glad to discuss it.
Contact: nestor@zumaya.com
Or schedule a call.